Coronavirus disease 2019 (COVID-19) is a respiratory tract infection caused by the new severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). An adequate T cell response is essential not only for fighting disease but also for the creation of immune memory. Thus, the present study aims to evaluate the T cells of patients with moderate, severe and critical COVID-19 not only at the time of illness but also 2 months after diagnosis to observe whether changes in this compartment persist. In this study, 166 COVID-19 patients were stratified into moderate/severe and critical disease categories. The maturation and activation of T cells were evaluated through flow cytometry. In addition, Treg cells were analysed. Until 15 days after diagnosis, patients presented a reduction in absolute and relative T lymphocyte counts. After 2 months, in moderate/severe patients, the counts returned to a similar level as that of the control group. In convalescent patients who had a critical illness, absolute T lymphocyte values increased considerably. Patients with active disease did not show differentiation of T cells. Nonetheless, after 2 months, patients with critical COVID-19 showed a significant increase in CD4 EMRA (CD45RA effector memory) T lymphocytes. Furthermore, COVID-19 patients showed delayed T cell activation and reduced CD8 suppressor T cells even 2 months after diagnosis. A reduction in CD4 Treg cells was also observed, and their numbers returned to a similar level as that of healthy controls in convalescent patients. The results demonstrate that COVID-19 patients have a delayed activation and differentiation of T cells. In addition, these patients have a great reduction of T cells with a suppressor phenotype.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1111/imm.13635 | DOI Listing |
IJID Reg
March 2025
Division of Pulmonary Medicine, Department of Medicine, Keio University School of Medicine, Shinjuku-ku, Japan.
Objectives: We examined shifts in labor productivity and their economic ramifications among adult patients with long COVID in Japan.
Methods: A total of 396 patients were categorized into three groups based on symptom progression: non-long COVID, long COVID recovered, and long COVID persistent. Patient-reported outcomes were assessed at three time intervals: 3, 6, and 12 months after COVID-19 diagnosis.
Front Cell Infect Microbiol
December 2024
Department of Clinical Laboratory, Tianjin First Central Hospital, School of Medicine, Nankai University, Tianjin, China.
Objective: COVID-19 has evolved into a seasonal coronavirus disease, characterized by prolonged infection duration and repeated infections, significantly increasing the risk of patients developing long COVID. Our research focused on the immune responses in asymptomatic and mild cases, particularly the critical factors influencing serum immunoglobulin G (IgG) levels and their predictive value.
Methods: We conducted a retrospective analysis on data from 1939 asymptomatic or mildly symptomatic COVID-19 patients hospitalized between September 2022 and June 2023.
Cureus
December 2024
Department of Emergency Medicine, Hitit University Erol Olçok Training and Research Hospital, Çorum, TUR.
Objective Proper preparation is necessary before performing certain procedures on a patient. Recently, videos created using social media content have been used as a preparation method. This has become particularly important in medical education since the COVID-19 pandemic.
View Article and Find Full Text PDFOman Med J
July 2024
Health Affairs, Ministry of Health, Muscat, Oman.
Objectives: Globally, the preparedness of frontline healthcare providers (HCPs) to deliver timely and appropriate medical care has emerged as a significant concern. The training of HCPs in containment measures is considered pivotal in elevating the quality of care for COVID-19 patients while simultaneously mitigating the risk of viral transmission to both fellow patients and HCPs. This study investigates the impact of training on HCPs readiness to manage COVID-19 patients in a tertiary hospital in Oman.
View Article and Find Full Text PDFCureus
November 2024
College of Osteopathic Medicine, Kansas City University of Medicine and Biosciences, Joplin, USA.
Background COVID-19 disease has caused a major global impact on health and mortality. This infection may predispose patients to thrombotic disease, caused by excessive inflammation, endothelial dysfunction, platelet activation, and stasis. In this study, we compared mortality rates in patients admitted to the hospital with the diagnosis of COVID-19, who also had the additional diagnosis of thrombosis with those who did not have thrombosis as an additional diagnosis.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!